312 related articles for article (PubMed ID: 24970287)
1. Association between serum concentration of vitamin D and 1-year mortality in stroke patients.
Daubail B; Jacquin A; Guilland JC; Khoumri C; Aboa-Eboulé C; Giroud M; Béjot Y
Cerebrovasc Dis; 2014; 37(5):364-7. PubMed ID: 24970287
[TBL] [Abstract][Full Text] [Related]
2. Serum Vitamin D Status as a Predictor of Prognosis in Patients with Acute Ischemic Stroke.
Park KY; Chung PW; Kim YB; Moon HS; Suh BC; Won YS; Kim JM; Youn YC; Kwon OS
Cerebrovasc Dis; 2015; 40(1-2):73-80. PubMed ID: 26184826
[TBL] [Abstract][Full Text] [Related]
3. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults.
Ginde AA; Scragg R; Schwartz RS; Camargo CA
J Am Geriatr Soc; 2009 Sep; 57(9):1595-603. PubMed ID: 19549021
[TBL] [Abstract][Full Text] [Related]
4. Serum 25-hydroxyvitamin D predicts severity and prognosis in stroke patients.
Daubail B; Jacquin A; Guilland JC; Hervieu M; Osseby GV; Rouaud O; Giroud M; Béjot Y
Eur J Neurol; 2013 Jan; 20(1):57-61. PubMed ID: 22632854
[TBL] [Abstract][Full Text] [Related]
5. A Reverse J-Shaped Association Between Serum 25-Hydroxyvitamin D and Cardiovascular Disease Mortality: The CopD Study.
Durup D; Jørgensen HL; Christensen J; Tjønneland A; Olsen A; Halkjær J; Lind B; Heegaard AM; Schwarz P
J Clin Endocrinol Metab; 2015 Jun; 100(6):2339-46. PubMed ID: 25710567
[TBL] [Abstract][Full Text] [Related]
6. Association between Admission Serum 25-Hydroxyvitamin D Levels and Functional Outcome of Thrombolyzed Stroke Patients.
Daumas A; Daubail B; Legris N; Jacquin-Piques A; Sensenbrenner B; Denimal D; Lemaire-Ewing S; Duvillard L; Giroud M; Béjot Y
J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):907-13. PubMed ID: 26830443
[TBL] [Abstract][Full Text] [Related]
7. The relationship of vitamin D status to risk of cardiovascular disease and mortality.
Skaaby T
Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634511
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D metabolites and fibroblast growth factor-23 in patients with left ventricular assist device implants: association with stroke and mortality risk.
Zittermann A; Morshuis M; Kuhn J; Pilz S; Ernst JB; Oezpeker C; Dreier J; Knabbe C; Gummert JF; Milting H
Eur J Nutr; 2016 Feb; 55(1):305-13. PubMed ID: 25657014
[TBL] [Abstract][Full Text] [Related]
9. Serum 25-hydroxyvitamin D deficiency predicts poor outcome among acute ischemic stroke patients without hypertension.
Zhang B; Wang Y; Zhong Y; Liao S; Lu Z
Neurochem Int; 2018 Sep; 118():91-95. PubMed ID: 29729873
[TBL] [Abstract][Full Text] [Related]
10. The risk of all-cause mortality is inversely related to serum 25(OH)D levels.
Saliba W; Barnett O; Rennert HS; Rennert G
J Clin Endocrinol Metab; 2012 Aug; 97(8):2792-8. PubMed ID: 22648653
[TBL] [Abstract][Full Text] [Related]
11. The inverse association between serum 25-hydroxyvitamin D and mortality may be modified by vitamin A status and use of vitamin A supplements.
Schmutz EA; Zimmermann MB; Rohrmann S
Eur J Nutr; 2016 Feb; 55(1):393-402. PubMed ID: 25701092
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
[TBL] [Abstract][Full Text] [Related]
13. Obesity and association of serum 25(OH)D levels with all-cause mortality.
Saliba W; Barnett-Griness O; Rennert G
Calcif Tissue Int; 2014 Sep; 95(3):222-8. PubMed ID: 24958474
[TBL] [Abstract][Full Text] [Related]
14. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study.
Schöttker B; Haug U; Schomburg L; Köhrle J; Perna L; Müller H; Holleczek B; Brenner H
Am J Clin Nutr; 2013 Apr; 97(4):782-93. PubMed ID: 23446902
[TBL] [Abstract][Full Text] [Related]
15. Effect of Vitamin D and calcium supplementation on ischaemic stroke outcome: a randomised controlled open-label trial.
Gupta A; Prabhakar S; Modi M; Bhadada SK; Kalaivani M; Lal V; Khurana D
Int J Clin Pract; 2016 Sep; 70(9):764-70. PubMed ID: 27561415
[TBL] [Abstract][Full Text] [Related]
16. Relationship of very low serum 25-hydroxyvitamin D
Maalmi H; Walter V; Jansen L; Chang-Claude J; Owen RW; Ulrich A; Schöttker B; Hoffmeister M; Brenner H
Eur J Epidemiol; 2017 Nov; 32(11):961-971. PubMed ID: 28884317
[TBL] [Abstract][Full Text] [Related]
17. Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart disease.
Grandi NC; Breitling LP; Vossen CY; Hahmann H; Wüsten B; März W; Rothenbacher D; Brenner H
Am Heart J; 2010 Jun; 159(6):1044-51. PubMed ID: 20569718
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D Supplementation Trials Aimed at Reducing Mortality Have Much Higher Power When Focusing on People with Low Serum 25-Hydroxyvitamin D Concentrations.
Brenner H; Jansen L; Saum KU; Holleczek B; Schöttker B
J Nutr; 2017 Jul; 147(7):1325-1333. PubMed ID: 28539415
[No Abstract] [Full Text] [Related]
19. Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study.
Drechsler C; Verduijn M; Pilz S; Dekker FW; Krediet RT; Ritz E; Wanner C; Boeschoten EW; Brandenburg V;
Nephrol Dial Transplant; 2011 Mar; 26(3):1024-32. PubMed ID: 20947538
[TBL] [Abstract][Full Text] [Related]
20. Association of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone with mortality among middle-aged and older European men.
Lee DM; Vanderschueren D; Boonen S; O'Neill TW; Pendleton N; Pye SR; Ravindrarajah R; Gielen E; Claessens F; Bartfai G; Casanueva FF; Finn JD; Forti G; Giwercman A; Han TS; Huhtaniemi IT; Kula K; Lean ME; Punab M; Wu FC;
Age Ageing; 2014 Jul; 43(4):528-35. PubMed ID: 24375224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
